Cantargia
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Scheelevägen 27, Lund, Skane, 223 63, Sw...Phone Number
+46 462756260Website
www.cantargia.comRevenue
-Stock Symbol
CANTAIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Cantargia
Cantargia AB, a biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.Explore more
Cantargia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cantargia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cantargia had a recent Job posting/layoffs
Check if Cantargia has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Cantargia has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Cantargia, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Cantargia
Earning: See what the market has to say on Cantargia recently announced quarterly report
Product Launch: Get notified when Cantargia launches new products
Check out if Cantargia is spiking on competitors!
Recommended Actions
Find VP level buyers at Cantargia
Find 3 more new buyers
Company Profile Activity
Activity Insights
Cantargia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cantargia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cantargia.
Cantargia financials insights
Gather financial insights about Cantargia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Debt
$5.2M
Cantargia Tech Stack
A closer look at the technologies used by Cantargia
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
Cantargia News & Media
Cantargia Secures SEK 50 Million Financing to Extend Financial Runway - TipRanks.com
An update from Cantargia AB ( ($SE:CANTA) ) is now available. Cantargia AB has secured a SEK 50 million loan agreement with Fenja Capital II A/S, extending its fina...Cantargia Announces Resignation of Liselotte Larsson as Chief Operating Officer
Cantargia announced that its Chief Operating Officer , Liselotte Larsson has resigned and will continue her career outside Cantargia. She will depart her role by mid-October, 2024. Liselotte Larsson...Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023
LUND, Sweden, April 4, 2023 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day focusing on new clinical results and biomarker data for its lead asset, the IL1RAP-binding antibody nadunolimab (CAN04), in pancreatic cancer (PDAC)...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cantargia
Sign Up For FreeTo access detailed company insights
Cantargia AB, a biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.... Read More
